Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET

Código QR

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET

Kathrin Kahnert,1 Rudolf A Jörres,2 Tanja Lucke,2 Franziska C Trudzinski,3 Pontus Mertsch,1 Christiane Bickert,1 Joachim H Ficker,4 Jürgen Behr,1 Robert Bals,5 Henrik Watz,6 Tobias Welte,7 Claus F Vogelmeier,8 Peter Alter8 On behalf of COSYCONET Study Group1Department of Medicine V, University Hospi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	chronic obstructive pulmonary disease oral corticosteroids inhaled corticosteroids anti-inflammatory metformin diabetes Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/3ed67e18c99f4eb899a01d7d17486dae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Estrategia terapéutica para prevenir la remodelación de las vías aéreas
por: Carrasco C.,Edgardo
Publicado: (2004)

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021)

Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma
por: Andrew Li, et al.
Publicado: (2021)

Effect of Inhaled Corticosteroids on Blood Glucose Homeostasis in Asthmatic Children
por: Alshaimaa Essam, et al.
Publicado: (2020)

Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations
por: Danforth P. Miller, et al.
Publicado: (2021)

Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)
por: Sainan Bian, et al.
Publicado: (2021)

Management of asthma in the elderly patient
por: Melani AS
Publicado: (2013)

Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
por: Selena deWasseige, et al.
Publicado: (2021)

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi JH, et al.
Publicado: (2021)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
por: Massin P, et al.
Publicado: (2016)

Rapid successful management of diffuse alveolar hemorrhage as the primary presentation of chlorine gas inhalation; A rare case report
por: samaneh kakhki, et al.
Publicado: (2021)

Factores asociados a respuesta favorable de tratamiento corticoidal en pacientes con polirradiculoneuropatía desmielinizante inflamatoria crónica
por: Fuentealba S.,Mario, et al.
Publicado: (2020)

Tratamiento no antimicrobiano de infecciones
por: Pérez G,Jorge
Publicado: (2003)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Fabiana Furci, et al.
Publicado: (2021)

Uso antenatal de corticosteóide e evolução clínica de recém-nascidos pré-termo
Publicado: (2006)

Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure
por: Sebastian Voicu, et al.
Publicado: (2021)

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
por: Svendsen MT, et al.
Publicado: (2016)

Strongyloides stercoralis: Un parásito subestimado
por: HERNANDEZ-CHAVARRIA,FRANCISCO
Publicado: (2001)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Yong Suk Jo, et al.
Publicado: (2021)

Efficacy and predictive factors of response to intra-articular corticosteroids in knee osteoarthritis
por: Parnaz Heidari, et al.
Publicado: (2020)

Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy
por: Kerasia-Maria Plachouri, et al.
Publicado: (2021)

Surgical versus Nonsurgical Multimodality Treatment in an Idiopathic Frozen Shoulder: A Retrospective Study of Clinical and Functional Outcomes
por: Wojciech Satora, et al.
Publicado: (2021)

Dual intestinal parasitosis unmasked by treatment for gastrointestinal sarcoidosis
por: Olutobi Ojuawo, et al.
Publicado: (2021)

Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
por: Brawer AE
Publicado: (2016)

A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
por: Alberto Utrero-Rico, et al.
Publicado: (2021)

Occurrence of Adrenal Suppression in Patients Having Sepsis in Indian Population and Impact of Corticosteroid Supplementation on Its Overall Survival
por: Kamalakanta Swain, et al.
Publicado: (2021)

A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
por: Rowawi R, et al.
Publicado: (2020)

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial
por: Palacio-Pastrana C, et al.
Publicado: (2020)

Successful induction treatment of bullous pemphigoid using reslizumab: a case report
por: Hyo-In Rhyou, et al.
Publicado: (2021)

Comparison of Methylprednisolone Injection Versus Diclofenac Injection in Treatment of Trigger Finger
por: S Mohammadi Jami, et al.
Publicado: (2020)

Corticosteroid response in children with nephrotic syndrome, Amirkola Children Hospital, 1994-2001
por: H Sorkhi, et al.
Publicado: (2002)

Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment
por: Nitin Goel, et al.
Publicado: (2021)

Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potentialCapsule Summary
por: Vivian Laquer, MD, et al.
Publicado: (2022)

Editorial: Nephrotic Syndrome in Children
por: Sami A. Sanjad, et al.
Publicado: (2021)

Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
por: Hiroyuki Goto, et al.
Publicado: (2021)

Clinical Implications of Second and Third Trimester Surveillance Ultrasounds of Growth-Restricted Fetuses
por: Amanda M. Craig, et al.
Publicado: (2021)

Effect of Different Corticosteroid Regimens on the Outcome of Severe COVID-19-Related Acute Respiratory Failure. A Retrospective Analysis
por: Michele Umbrello, et al.
Publicado: (2021)

COMPARISON OF VARIOUS INTRA-ARTICULAR CORTICOSTEROIDS IN KNEE OSTEOARTHRITIS MANAGEMENT
por: Ammara Arif, et al.
Publicado: (2019)

Role of steroids in the treatment of bacterial keratitis
por: Palioura S, et al.
Publicado: (2016)

Analysis of Funding Source and Spin in the Reporting of Studies of Intravitreal Corticosteroid Therapy for Diabetic Macular Edema: A Systematic Review
por: Nithianandan H, et al.
Publicado: (2020)